Registered entities
Lyell Immunopharma, Inc.
Reg. No. 1806952United States
LYELL IMMUNOPHARMA, INC
Reg. No. 83-1300510United States
Social engagement
Social engagement: 21.5K social following, 8 posts in the last 12 months — below the industry typical range.
Investor mix
7 investors on record; lead investors include GSK, Sahsen Ventures.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 71% |
| Other / undisclosed | 2 | 29% |
Hiring activity
Hires occasionally
2 roles tracked across 2 of the last 12 months
9 Nov 2025 · Talent Acquisition Manager · South San Francisco
8 Oct 2025 · Associate Director, Clinical Operations · Seattle
25 Sep 2025 · Vice President, Medical Affairs · South San Francisco
Based on job postings tracked across public sources.
Recent activity
12 Jun 2026
Event
European Hematology Association (EHA) 2026 Congress
8 Jun 2026
Event
Goldman Sachs 47th Annual Global Healthcare Conference
19 May 2026
Event
H.C. Wainwright 4th Annual BioConnect Investor Conference and Stifel Virtual Targeted Oncology Forum